Clinical Trial Update: Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating valproic acid for hyperactive or mixed delirium in ICU was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperactive Delirium
• Mixed Delirium

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Stanford University | Conditions: Hyperactive Delirium, Mixed Delirium | Phase 4 | Status: TERMINATED | Results posted: 2019-06-26